Alicia Castañeda
Hospital Sant Joan de Déu Barcelona(ES)Clark University(US)Université Paris-Saclay(FR)Institut Gustave Roussy(FR)Kaiser Permanente Anaheim Medical Center(US)McGill University(CA)University of Pennsylvania(US)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Cancer, Hypoxia, and Metabolism, Sarcoma Diagnosis and Treatment, Lung Cancer Research Studies, Neuroendocrine Tumor Research Advances
Most-Cited Works
- → Naxitamab combined with granulocyte‐macrophage colony‐stimulating factor as consolidation for high‐risk neuroblastoma patients in complete remission(2021)29 cited
- → Transverse myelitis as an unexpected complication following treatment with dinutuximab in pediatric patients with high‐risk neuroblastoma: A case series(2017)27 cited
- → Prognostic value of patient‐derived xenograft engraftment in pediatric sarcomas(2021)27 cited
- → GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)(2017)26 cited
- → Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes(2023)23 cited
- → The Role of Autologous Stem-Cell Transplantation in High-Risk Neuroblastoma Consolidated by anti-GD2 Immunotherapy. Results of Two Consecutive Studies